Institutional Ownership Biocryst Pharmaceuticals Inc (BCRX)
This table provides information about the institutional ownership of Biocryst Pharmaceuticals Inc (BCRX). We have compiled data on the 277 institutions that hold shares in the stock, with a total of 167 Million shares, which have been reported (via 13F filing form) to have a value of $1.31 Billion.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Bell Investment Advisors, Inc
Oakland, CA |
Feb 07, 2025 Q4 2024 |
107
shares
|
$841
0.0% of portfolio
|
Q2 2024
New holding
|
|
Cornerstone Planning Group LLC
Fairfield, NJ |
Jan 29, 2025 Q4 2024 |
100
shares
|
$786
0.0% of portfolio
|
Q3 2024
New holding
|
|
Parallel Advisors, LLC
|
Feb 10, 2025 Q4 2024 |
93
shares
|
$730
0.0% of portfolio
|
Q4 2024
Reduced 25.0%
|
|
Whipplewood Advisors, LLC
Littleton, CO |
Feb 04, 2025 Q4 2024 |
72
shares
|
$565
0.0% of portfolio
|
Q4 2024
New holding
|
|
Ifp Advisors, Inc
|
Feb 04, 2025 Q4 2024 |
53
shares
|
$416
0.0% of portfolio
|
Q4 2024
New holding
|
|
Harbour Investments, Inc.
Madison, WI |
Feb 10, 2025 Q4 2024 |
51
shares
|
$400
0.0% of portfolio
|
Q2 2022
New holding
|
|
Optiver Holding B.V.
Amsterdam, P7 |
Feb 14, 2025 Q4 2024 |
49
shares
|
$385
0.0% of portfolio
|
Q4 2024
New holding
|
|
Exane Derivatives
|
Jul 12, 2022 Q2 2022 |
32
shares
|
$251
0.0% of portfolio
|
Q2 2022
Reduced 99.57%
|
|
Covestor LTD
Boston, MA |
Feb 13, 2025 Q4 2024 |
17
shares
|
$133
0.0% of portfolio
|
Q4 2024
Added 6.25%
|
|
New Edge Advisors, LLC
New Orleans, LA |
Feb 13, 2025 Q4 2024 |
11
shares
|
$86
0.0% of portfolio
|
Q4 2024
New holding
|
|
Steward Financial Group LLC
|
Oct 20, 2023 Q3 2023 |
8
shares
|
$62
0.0% of portfolio
|
Q3 2023
New holding
|
|
Sbi Securities Co., Ltd.
Tokyo, M0 |
Feb 05, 2025 Q4 2024 |
4
shares
|
$31
0.0% of portfolio
|
Q4 2024
New holding
|
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
Feb 13, 2025 Q4 2024 |
0
shares
|
$0
0.0% of portfolio
|
Q4 2024
New holding
|